Cigna Group (NYSE:CI) Price Target Raised to $297.00

Cigna Group (NYSE:CI) had its target price lifted by Leerink Partners from $270.00 to $297.00 in a research report sent to investors on Friday,MarketScreener reports. Leerink Partners currently has a market perform rating on the health services provider’s stock.

Other equities research analysts have also issued reports about the company. Jefferies Financial Group reiterated a “buy” rating and issued a $310.00 price objective on shares of Cigna Group in a research note on Monday, November 3rd. The Goldman Sachs Group lowered their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Morgan Stanley reaffirmed an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. Finally, Truist Financial increased their target price on shares of Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research report on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $323.16.

Cigna Group Trading Up 2.7%

Shares of CI stock opened at $292.29 on Friday. The firm has a fifty day moving average of $274.77 and a 200-day moving average of $283.69. The stock has a market cap of $78.08 billion, a price-to-earnings ratio of 13.18, a P/E/G ratio of 1.04 and a beta of 0.27. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the business earned $6.64 EPS. The firm’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is currently 27.23%.

Institutional Trading of Cigna Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after purchasing an additional 414,834 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Dodge & Cox grew its holdings in shares of Cigna Group by 4.0% in the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after buying an additional 354,615 shares during the period. Sanders Capital LLC increased its position in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after buying an additional 35,150 shares in the last quarter. Finally, Norges Bank acquired a new stake in Cigna Group during the 2nd quarter worth $1,110,426,000. 86.99% of the stock is owned by institutional investors.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.